Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mi | My body. My choice. Are we all talking about the same thing? | ||
Mi | BeiGene announces positive phase 3 trial results for liver cancer treatment | ||
Mi | Sanofi halts recruitment for trials assessing MS treatment | ||
Mi | Merck and Cerevance to research novel targets in Alzheimer's disease | ||
Mi | Michael J Fox Foundation awards Koneksa second research grant | ||
Mi | FDA approves Bot Image's AI software for the detection and diagnosis of prostate cancer | ||
Di | Strategic commitment | ||
Di | Pfizer set to acquire Global Blood Therapeutics in deal worth $5.4bn | ||
Di | AstraZeneca and Daiichi Sankyo get FDA approval for breast cancer drug | ||
Di | NHS England launches hepatitis C screening scheme to reach 2030 elimination goal | ||
Di | Bayer's Nubeqa receives FDA approval to treat metastatic prostate cancer | ||
Di | Valneva and Pfizer initiate phase 3 Lyme disease vaccine study | ||
Mo | Born strategic - Why great strategists are both born and made | ||
Mo | AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn | ||
Mo | ONS records a continued fall in UK COVID-19 infections | ||
Mo | ICR research shows how skin cancer cells invade new tissues | ||
Mo | bluebird bio reveals plans to launch two gene therapies | ||
Mo | UK government's 'science superpower' ambitions to fail without clear plan, Lords committee warns | ||
Fr | Amgen acquires ChemoCentryx in $3.7bn cash deal | ||
Fr | Gilead Sciences set to acquire MiroBio in deal worth over $400m | ||
Fr | NHS England to roll out continuous glucose monitors to all those with type 1 diabetes | ||
Fr | Sanofi and Innovent Biologics to develop oncology drugs for patients in China | ||
Fr | WHO launches funding appeal for greater Horn of Africa prompted by food crisis | ||
04.08. | The patient voice - the value of patient-reported outcomes in HTA | ||
04.08. | AstraZeneca and MSD's breast cancer drug Lynparza receives EC approval |